Molecular Characterization and Detection of Macrolide and Fluoroquinolone Resistance Determinants in Mycoplasma genitalium in South Africa, 2015 to 2018
Abstract:A low prevalence of macrolide resistance–associated mutations in Mycoplasma genitalium strains obtained from genital discharge specimens was observed in South Africa over a 4-year surveillance period.
“…Nevertheless, AMR in N. gonorrhoeae and M. genitalium is on the rise globally and evaluation for AMR should be included in any diagnostic work-up. 24,45,46 It is essential to take a thorough sexual and clinical history, and to conduct a physical examination of all patients presenting with persistent or recurrent MUDS or VDS. If reinfection, new infection, or poor treatment adherence is likely, then retreatment with the same empirical STI regimen is indicated.…”
Section: Clinical Management Of Patients With Recurrent or Persistent...mentioning
confidence: 99%
“…Nevertheless, AMR in N. gonorrhoeae and M. genitalium is on the rise globally and evaluation for AMR should be included in any diagnostic work-up. 24 , 45 , 46 …”
Section: Clinical Management Of Patients With Recurrent or Persistent...mentioning
confidence: 99%
“…Macrolide resistance has emerged globally; however, limited data for the African region (including South Africa and Kenya) suggest that local macrolide resistance levels are still low. 24 , 46 , 56 , 59 , 62 In the absence of resistance testing and given the widespread use of moxifloxacin (an alternative treatment) in management of tuberculosis, a course of azithromycin is still recommended as first-line treatment of M. genitalium ( Table 6 ). Resistance-guided therapy is preferred in settings where macrolide resistance testing is available.…”
Section: Pathogen-directed Treatment Of Specific Sexually Transmitted...mentioning
“…Nevertheless, AMR in N. gonorrhoeae and M. genitalium is on the rise globally and evaluation for AMR should be included in any diagnostic work-up. 24,45,46 It is essential to take a thorough sexual and clinical history, and to conduct a physical examination of all patients presenting with persistent or recurrent MUDS or VDS. If reinfection, new infection, or poor treatment adherence is likely, then retreatment with the same empirical STI regimen is indicated.…”
Section: Clinical Management Of Patients With Recurrent or Persistent...mentioning
confidence: 99%
“…Nevertheless, AMR in N. gonorrhoeae and M. genitalium is on the rise globally and evaluation for AMR should be included in any diagnostic work-up. 24 , 45 , 46 …”
Section: Clinical Management Of Patients With Recurrent or Persistent...mentioning
confidence: 99%
“…Macrolide resistance has emerged globally; however, limited data for the African region (including South Africa and Kenya) suggest that local macrolide resistance levels are still low. 24 , 46 , 56 , 59 , 62 In the absence of resistance testing and given the widespread use of moxifloxacin (an alternative treatment) in management of tuberculosis, a course of azithromycin is still recommended as first-line treatment of M. genitalium ( Table 6 ). Resistance-guided therapy is preferred in settings where macrolide resistance testing is available.…”
Section: Pathogen-directed Treatment Of Specific Sexually Transmitted...mentioning
“…genitalium . Whole genome-based SNP phylogeny SLSB mgp B genotyping studies used the number of repeats in gene MG_309 typing in epidemiological assessments [4, 7, 9–14, 19]. In addition to the whole genome-based study, SLSB mgp B genotyping is the most common and widely used method to study the epidemiology of infections [4, 7, 9–14].…”
Section: Full-textmentioning
confidence: 99%
“…Reliable and effective genotyping methods are key to detailed epidemiological and evolutionary studies of M. genitalium. Whole genome-based SNP phylogeny SLSB mgpB genotyping studies used the number of repeats in gene MG_309 typing in epidemiological assessments [4,7,[9][10][11][12][13][14]19]. In addition to the whole genome-based study, SLSB mgpB genotyping is the most common and widely used method to study the epidemiology of infections [4,7,[9][10][11][12][13][14].…”
Introduction. Antimicrobial resistance (AMR) among
Mycoplasma genitalium
is a global issue. Understanding the transmission dynamics of infection is an important factor in reducing the occurrence of AMR.
Hypothesis/Gap Statement. There is limited information on the genotyping and AMR traits of
M. genitalium
.
Aims. Single-locus sequence-based (SLSB) mgpB sequence typing and genetic diversity analyses of AMR
M. genitalium
isolated from patients in the Republic of Korea were performed to clarify the transmission dynamics and eludicate proper management.
Methodology. Sanger sequencing of mgpB, 23S rRNA, parC and gyrA genes from a total of 103
M
.
genitalium
-positive specimens from 89 patients was carried out.
Results. Twenty-seven different mgpB genotypes (GTs) were identified; 12 had been reported previously and 15 had not. GT7 and GT8 occurred frequently (n=38, 36.89 %, and n=16, 15.53 %, respectively). The genetic diversity of the AMR-determining sites was randomly dispersed among the different GTs. However, these GTs were classified into two phylogenetically distinct clusters that were significantly correlated with patient age and genetic diversity at positions 2058 and 2059 in the 23S rRNA gene. The GTs of 20 consecutive samples from 6 patients were compared to investigate temporal changes in GTs. One specimen changed its GT during follow-up, suggesting a new infection.
Conclusions. mgpB sequence typing can be a reliable tool for epidemiological studies. Two clusters have different characteristics in terms of genetic diversity. The cluster with genetic diversity in the AMR-determining site may be explained by the high prevalence of the specimens and subsequent antimicrobial exposure during the study period.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.